Company Information

Operating, investing and financing cash flows.

Cash Flow

MOREPEN LABORATORIES LTD.

NSE Code: MOREPENLABEQ
BSE Code: 500288
ISIN: INE083A01026
Industry: Pharmaceuticals

Financial Data

Cash Flow

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00

Net Profit/Loss Before Extraordinary Items And Tax	89.26	137.59	148.98	63.04	125.54

Net CashFlow From Operating Activities	20.47	29.08	77.36	-102.12	-66.38
Net Cash Used In Investing Activities	-119.02	-280.42	-83.60	-36.20	-22.64
Net Cash Used From Financing Activities	97.12	260.47	0.28	144.20	63.93

Net Inc/Dec In Cash And Cash Equivalents	-1.43	9.12	-5.96	5.88	-25.09
Cash And Cash Equivalents Begin of Year	24.43	15.30	21.26	15.38	40.47
Cash And Cash Equivalents End Of Year	23.00	24.43	15.30	21.26	15.38

Five-year consolidated Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00

Net Profit/Loss Before Extraordinary Items And Tax	119.92	155.11	135.42	55.76	126.70

Net CashFlow From Operating Activities	32.64	32.06	73.37	-91.17	-57.76
Net Cash Used In Investing Activities	-123.42	-321.51	-83.30	-46.51	-31.68
Net Cash Used From Financing Activities	97.40	299.89	5.20	143.54	63.85

Net Inc/Dec In Cash And Cash Equivalents	6.62	10.44	-4.72	5.86	-25.58
Cash And Cash Equivalents Begin of Year	24.57	16.95	21.67	15.80	41.39
Cash And Cash Equivalents End Of Year	31.19	27.38	16.95	21.67	15.80

Source: Financial statements as reported by the company.